Fort Washington Investment Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$52.5M Buy
208,716
+858
+0.4% +$185K 0.26% 101
2026
Q1
$45.2M Buy
207,858
+9,204
+5% +$2.04M 0.25% 103
2025
Q4
$45.4M Buy
198,654
+2,141
+1% +$488K 0.24% 104
2025
Q3
$45.5M Sell
196,513
-26,627
-12% -$5.42M 0.25% 98
2025
Q2
$41.4M Sell
223,140
-3,751
-2% -$697K 0.24% 101
2025
Q1
$47.5M Sell
226,891
-42,337
-16% -$8.23M 0.29% 86
2024
Q4
$47.8M Buy
269,228
+13,833
+5% +$2.54M 0.29% 86
2024
Q3
$50.4M Sell
255,395
-43
-0% -$8.03K 0.31% 84
2024
Q2
$43.8M Sell
255,438
-2,375
-0.9% -$393K 0.29% 86
2024
Q1
$46.9M Sell
257,813
-16,665
-6% -$2.87M 0.3% 85
2023
Q4
$42.5M Buy
274,478
+2,019
+0.7% +$294K 0.29% 87
2023
Q3
$40.6M Buy
272,459
+3,125
+1% +$459K 0.31% 88
2023
Q2
$36.3M Sell
269,334
-264
-0.1% -$38.7K 0.26% 94
2023
Q1
$43M Sell
269,598
-4,716
-2% -$721K 0.32% 87
2022
Q4
$44.3M Sell
274,314
-3,985
-1% -$611K 0.34% 85
2022
Q3
$37.4M Sell
278,299
-11,488
-4% -$1.65M 0.31% 94
2022
Q2
$44.4M Sell
289,787
-24,814
-8% -$3.79M 0.34% 85
2022
Q1
$51M Sell
314,601
-186,508
-37% -$27.1M 0.32% 88
2021
Q4
$67.8M Sell
501,109
-39,168
-7% -$4.63M 0.41% 68
2021
Q3
$58.3M Buy
540,277
+396,901
+277% +$45.4M 0.37% 70
2021
Q2
$16.1M Buy
143,376
+182
+0.1% +$20.5K 0.14% 107
2021
Q1
$15.5M Buy
143,194
+1,821
+1% +$195K 0.15% 103
2020
Q4
$15.1M Buy
141,373
+949
+0.7% +$91.2K 0.16% 96
2020
Q3
$12.3M Sell
140,424
-4,343
-3% -$409K 0.13% 105
2020
Q2
$14.2M Buy
144,767
+10,456
+8% +$921K 0.16% 104
2020
Q1
$10.2M Buy
134,311
+4,863
+4% +$414K 0.14% 122
2019
Q4
$11.5M Buy
129,448
+28,921
+29% +$2.4M 0.12% 179
2019
Q3
$7.61M Buy
100,527
+27,562
+38% +$1.89M 0.08% 194
2019
Q2
$5.31M Sell
72,965
-2,960
-4% -$233K 0.06% 206
2019
Q1
$6.12M Sell
75,925
-518
-0.7% -$42.4K 0.07% 196
2018
Q4
$7.05M Sell
76,443
-27,514
-26% -$2.42M 0.09% 176
2018
Q3
$9.83M Sell
103,957
-8,151
-7% -$773K 0.1% 184
2018
Q2
$10.4M Sell
112,108
-125
-0.1% -$12.2K 0.11% 189
2018
Q1
$10.6M Sell
112,233
-20,536
-15% -$2.26M 0.11% 188
2017
Q4
$12.8M Sell
132,769
-210
-0.2% -$19.8K 0.13% 189
2017
Q3
$11.8M Buy
132,979
+4,378
+3% +$333K 0.18% 84
2017
Q2
$9.32M Sell
128,601
-500
-0.4% -$33.6K 0.15% 95
2017
Q1
$8.41M Sell
129,101
-832
-0.6% -$52.3K 0.13% 104
2016
Q4
$8.14M Sell
129,933
-1,350
-1% -$82.4K 0.14% 97
2016
Q3
$8.28M Sell
131,283
-7,402
-5% -$479K 0.15% 99
2016
Q2
$8.59M Sell
138,685
-450
-0.3% -$27.4K 0.16% 94
2016
Q1
$7.95M Sell
139,135
-11,353
-8% -$633K 0.15% 100
2015
Q4
$8.91M Sell
150,488
-9,881
-6% -$569K 0.18% 90
2015
Q3
$8.73M Buy
160,369
+96,385
+151% +$6.27M 0.18% 92
2015
Q2
$4.3M Sell
63,984
-8,150
-11% -$532K 0.08% 139
2015
Q1
$4.22M Sell
72,134
-56,392
-44% -$3.41M 0.08% 143
2014
Q4
$8.41M Sell
128,526
-3,567
-3% -$225K 0.17% 105
2014
Q3
$7.63M Sell
132,093
-19
-0% -$1.05K 0.16% 114
2014
Q2
$7.46M Sell
132,112
-675
-0.5% -$35.4K 0.14% 134
2014
Q1
$6.83M Sell
132,787
-17,035
-11% -$861K 0.15% 128
2013
Q4
$7.91M Sell
149,822
-3,039
-2% -$149K 0.18% 101
2013
Q3
$6.84M Buy
152,861
+19,248
+14% +$853K 0.16% 102
2013
Q2
$5.52M Buy
+133,613
New +$5.84M 0.13% 178

Other funds holding ABBV

Fort Washington Investment Advisors's ABBV Position: Q2 2026 in Review

Fort Washington Investment Advisors increased its AbbVie (ABBV) stake by 0.41% in Q2 2026, buying an estimated $185K and bringing the position to 208,716 shares worth $52.5M. The position accounts for 0.26% of the portfolio, ranked #101.

Fort Washington Investment Advisors first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. The position peaked at $67.8M in Q4 2021. 1,623 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Fort Washington Investment Advisors held 208,716 shares of AbbVie worth $52.5M as of Q2 2026.
  • Fort Washington Investment Advisors bought 858 AbbVie shares in Q2 2026, an estimated $185K.
  • AbbVie made up 0.26% of Fort Washington Investment Advisors's portfolio in Q2 2026, its #101 holding.
  • Fort Washington Investment Advisors first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
  • Fort Washington Investment Advisors's AbbVie position peaked at $67.8M in Q4 2021.
  • 1,623 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Fort Washington Investment Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.